Evidence map›Paper›PMID 41583490›Full record

ArticleFrontiers in immunology2025

Thyroid function and liver fibrosis: FT3 levels are inversely and independently correlated with enhanced liver fibrosis score in solid organ transplant patients with dysglycemia.

Claudia Leanza, Maria Ausilia Giusti, Vitale Miceli, Giovanni Zito, Rosaria Tinnirello, Gioacchin Iannolo, Antonio Galante, Fabrizio Emanuele, Marco Amato, Giovanna Lo Iacono and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Claudia LeanzaUPMC Italy, Palermo, Italy.
Maria Ausilia GiustiUPMC Italy, Palermo, Italy.
Vitale MiceliDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Giovanni ZitoDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Rosaria TinnirelloDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Gioacchin IannoloDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Antonio GalanteUPMC Italy, Palermo, Italy.
Fabrizio EmanueleUPMC Italy, Palermo, Italy.
Marco AmatoUPMC Italy, Palermo, Italy.
Giovanna Lo IaconoDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Vincenzina Lo ReUPMC Italy, Palermo, Italy.
Salvatore GruttadauriaUPMC Italy, Palermo, Italy.
Aldo Eugenio CalogeroDepartment of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Massimo PinzaniDepartment of Research, IRCCS ISMETT, Palermo,  Italy.
Alessandro MattinaUPMC Italy, Palermo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Solid organ transplantation (SOT) is frequently complicated by dysglycemia and metabolic dysfunction-associated steatotic liver disease (MASLD), conditions that accelerate the development of liver fibrosis. Given the recognized thyroid-liver crosstalk, we investigated the association between thyroid function and the enhanced liver fibrosis (ELF) score in SOT recipients with diabetes or prediabetes. Methods: Seventy-one adult SOT recipients with diabetes or prediabetes, with ultrasound evidence of liver steatosis and/or a FIB-4 > 1.3, underwent standardized clinical phenotyping, biochemical profiling, thyroid hormone measurements, ELF testing, and liver stiffness measurement (LSM). Associations with ELF were assessed using correlation analyses and multivariable linear regression adjusted for age, sex, body mass index (BMI), transaminases, glycated haemoglobin, creatinine, haemoglobin, albumin, immunosuppressive drugs, glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy, and transplanted organ type. Results: Participants had a mean age of 63.1 ± 9.5 years and BMI of 27.8 ± 4.8 kg/m². Mean ELF was 9.21 ± 1.00 (low risk <9.8: 70%; intermediate 9.8-11.3: 27%; high ≥11.3: 3%). ELF correlated positively with age (r=0.43, p=0.0002), aspartate aminotransferase (AST; r=0.50, p<0.0001), alanine aminotransferase (ALT; r=0.33, p=0.0059) and creatinine (r=0.39, p=0.0009), and inversely with haemoglobin (r=-0.39, p=0.0009), albumin (r=-0.38, p=0.0024), controlled attenuation parameter (CAP) (r=-0.29, p=0.0171). Among thyroid variables, free triiodothyronine (FT3) correlated inversely with ELF score (r=-0.45, p=0.0003), while TSH and FT4 showed no significant association with ELF score (r=0.00, p=0.9859; r=-0.5, p=0.6891). In multivariable analysis (R²=0.67; p=0.0002), lower FT3 (β=-0.611 ± 0.288; p=0.0404) and age (β=0.029 ± 0.012; p=0.0304) remained independently associated with higher ELF. No association was found between ELF and LSM. Conclusions: In SOT recipients with dysglycemia lower FT3 levels were independently associated with increased ELF scores. This finding suggests a potential link between subtle variations in thyroid function and markers of fibrogenic activity in metabolically vulnerable transplant recipients. Prospective studies are warranted to elucidate the causal directionality of this association and its clinical relevance.

Indexed as

Liver CirrhosisOrgan TransplantationPrediabetic StateThyroid GlandTriiodothyronineAgedBiomarkersFemaleHumansMaleMiddle AgedThyroid Function TestsBiomarkersTriiodothyroninedysglycemiaELF scorefibrosisFT3immunosuppressionliver stiffnessMASLD/MASHsolid organ transplantation

Identifiers

PMID41583490
PMCPMC12823537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.